Position in PFE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,078,561
-$298,270 QoQ
Shares Held
86,319
+2.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#943
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Joel Isaacson & Co., LLC holds $52,580,622 across 13 Drug Manufacturers - General names. PFE ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,396 | $20,164,202 | |
| 2 | LLY |
ELI LILLY & Co
|
11,698 | $14,030,933 | |
| 3 | MRK |
Merck & Co., Inc.
|
43,718 | $5,617,763 | |
| 4 | AMGN |
Amgen Inc
|
8,040 | $2,911,444 | |
| 5 | ABBV |
AbbVie Inc.
|
8,694 | $2,187,758 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,637 | $2,168,643 | |
| 7 | PFE |
Pfizer Inc
This page
|
86,319 | $2,078,561 | |
| 8 | NVS |
Novartis AG
|
6,486 | $1,016,485 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,078,561 | 86,319 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,376,831 | 84,645 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,128,003 | 85,462 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,033,354 | 79,802 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,859,523 | 76,713 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,103,169 | 82,998 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,219,844 | 83,673 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $2,247,046 | 77,645 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,125,304 | 75,958 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,103,921 | 75,817 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,056,239 | 71,422 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,661,352 | 50,086 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,810,818 | 49,368 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,136,655 | 52,369 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,726,172 | 53,204 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,289,873 | 52,328 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,567,864 | 48,977 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,570,898 | 49,660 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $2,885,596 | 48,867 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,956,223 | 45,483 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,779,234 | 45,435 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $1,628,031 | 44,936 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,680,192 | 45,645 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $1,628,634 | 44,377 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $1,368,659 | 41,855 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,368,397 | 41,924 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||